TerrAscend Corp.

TSX:TSND.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.52 -1.61%

-$0.02 today

Market cap
$193.65M
Beta
2.04
P/E (TTM)
-2.5
EPS (TTM)
-$0.26
52W Low $0.33High $2.00

Volume 0.26M

Average 0.31M

TSND.TO Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

TerrAscend Corp.TSX: TSND.TO

Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other current liabilities rises 392.6% from a year ago

Other current liabilities stood at $6.95M at the end of Q1 FY2026, up 392.6% from a year earlier and down 64.7% from the prior quarter. Over 3 fiscal years it compounded at +23.4% a year.

Context

  • Other current liabilities amounted to 1.3% of total assets at the end of Q1 FY2026, up 1.0 pp from a year earlier.
  • Other current liabilities increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other current liabilities keeps rising in the next quarterly balance sheet after a +392.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.95M-64.7% QoQ
Last fiscal yearDec 2025
$14.21M+1501.7% YoY
Year agoMar 2025
$1.41M+392.6% since
Other Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+392.6%——
1 year+1501.7%——
3-year CAGR+23.4%——
5-year CAGR——
10-year CAGR——

Other Current Liabilities history

USD · from the balance sheet

Latest · FY2025
14.21M USD
Year-over-year change
+1501.7%
4-year CAGR
+1.3%

Other Current Liabilities vs competitors

How TSND.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +392.6% is the 3rd highest of 8, against a peer median of +51.1%.
  • Other current liabilities amounts to 1.3% of total assets for TSND.TO, versus a peer median of 2.8%.
TSND.TO Competitors
Other Current Liabilities for TSND.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WEED.TOCanopy Growth CorporationMar 2026CA$74.64M CAD+135.2%-1.2%6.7%
ACB.TOAurora Cannabis Inc.Mar 2026CA$44.93M CAD+2560.3%-2.9%7.5%
DR.TOMedical Facilities CorporationMar 2026$15.57M USD+4.4%+14.0%5.6%
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$14.65M CAD+29.4%—2.8%
HLS.TOHLS Therapeutics Inc.Mar 2026$13.71M USD+51.1%+20.1%10.5%
TSND.TOTerrAscend Corp.Mar 2026$6.95M USD+392.6%+23.4%1.3%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$246.6K USD+564.6%-2.7%0.2%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$187 USD——0.0%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$0 CAD-100.0%—0.0%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026-$7.87K USD——0.0%
Peer median (excluding TSND.TO) —+51.1%-1.2%2.8%

Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents100.55M36.31M22.24M26.38M37.46M
Short-term Investments03.63M1.91M1.73M361.34K
Net Receivables12.38M22.66M19.05M27.15M16.87M
Inventory35.79M46.75M51.68M48.8M33.99M
Other Current Assets38.88M7.55M8M373.79K21.23M
Total Current Assets171.05M123.1M102.89M104.43M109.91M
Property, Plant & Equipment (Net)178.79M332.78M239.66M324.13M156.34M
Goodwill89.57M91.15M106.93M153.73M109.57M
Intangible Assets167.02M241.88M215.85M243.84M167.01M
Long-term Investments68.05M0609.48K00
Tax Assets5.01M0(609.48K)19.21M10.47M
Other Non-current Assets8.47M120.6M1.19M(238.26M)13.54M
Total Non-current Assets516.92M786.41M563.63M502.8M456.93M
Total Assets734.69M951.93M666.52M607.23M566.83M
Account Payables27.69M44.35M49.9M46.73M37.57M
Short-term Debt8.26M52.02M137.74M6.76M17.16M
Tax Payables12.15M31.31M6.3M11.53M0
Deferred Revenue1.35M3.98M4.15M5.13M3.99M
Other Current Liabilities13.49M7.55M717K887K14.21M
Total Current Liabilities65.64M139.15M207M78.53M79.79M
Long-term Debt169.74M147.17M68.9M192.58M210.36M
Deferred Tax Liabilities14.27M59.6M17.18M8.43M18.48M
Deferred Revenue (Non-current)067.1M000
Other Non-current Liabilities84.17M3.31M104.09M107.7M130.87M
Total Non-current Liabilities284.41M329.04M218.78M351.89M388.21M
Total Liabilities445.64M516.16M425.78M430.41M467.99M
Common Stock00000
Retained Earnings(312.03M)(623.86M)(928.51M)(778.51M)(863.17M)
Accumulated OCI2.8M2.1M1.8M3.01M1.98M
Other Stockholders Equity00573.16K00
Minority Interest6.78M3.22M(2.33M)(207.1K)1.53M
Total Equity289.05M435.77M240.74M176.82M98.84M
Total Debt209.67M248.25M255.7M246.18M256.49M
Net Debt166.39M298.58M233.46M219.8M219.03M

TerrAscend Corp.

TSX:TSND.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.